Must See: Do You Invest in Midcap Stocks? Here's a Great News for You
Here is the latest financial fact sheet of KRSNAA DIAGNOSTICS. For more details, see the KRSNAA DIAGNOSTICS quarterly results and KRSNAA DIAGNOSTICS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.7 |
No. of shares | m | 32.29 |
1 Week | % | -5.9 |
1 Month | % | 2.5 |
1 Year | % | 19.2 |
52 week H/L | Rs | 788.6/448.7 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
KRSNAA DIAGNOSTICS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | 1,100 | 655 | |
Low | Rs | NA | NA | NA | 480 | 354 | |
Sales per share (Unadj.) | Rs | 405.5 | 500.8 | 609.9 | 145.0 | 155.1 | |
Earnings per share (Unadj.) | Rs | -112.5 | -217.0 | 284.5 | 21.8 | 19.8 | |
Diluted earnings per share | Rs | -18.0 | -34.7 | 57.3 | 21.2 | 19.2 | |
Cash flow per share (Unadj.) | Rs | -62.8 | -154.1 | 342.1 | 35.0 | 36.9 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 2.50 | 2.75 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 2.43 | 2.67 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0.3 | 0.5 | |
Book value per share (Unadj.) | Rs | -164.6 | -381.7 | 355.5 | 217.3 | 234.4 | |
Adj. book value per share | Rs | -26.3 | -61.0 | 71.6 | 211.3 | 228.0 | |
Shares outstanding (eoy) | m | 5.16 | 5.16 | 6.50 | 31.40 | 31.40 | |
Price / Sales ratio | x | 0 | 0 | 0 | 5.4 | 3.3 | |
Avg P/E ratio | x | 0 | 0 | 0 | 36.3 | 25.5 | |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 22.6 | 13.7 | |
Price / Book Value ratio | x | 0 | 0 | 0 | 3.6 | 2.2 | |
Dividend payout | % | 0 | 0 | 0 | 11.5 | 13.9 | |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 24,796 | 15,840 | |
Total wages/salary | Rs m | 183 | 231 | 299 | 542 | 746 |
KRSNAA DIAGNOSTICS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 2,092 | 2,584 | 3,965 | 4,555 | 4,871 | |
Other income | Rs m | 51 | 130 | 2,650 | 149 | 194 | |
Total revenues | Rs m | 2,143 | 2,714 | 6,615 | 4,704 | 5,065 | |
Gross profit | Rs m | -376 | -1,142 | 938 | 1,315 | 1,223 | |
Depreciation | Rs m | 256 | 324 | 374 | 414 | 538 | |
Interest | Rs m | 196 | 247 | 259 | 185 | 77 | |
Profit before tax | Rs m | -777 | -1,583 | 2,955 | 865 | 802 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -197 | -464 | 1,105 | 181 | 181 | |
Profit after tax | Rs m | -581 | -1,120 | 1,849 | 684 | 621 | |
Gross profit margin | % | -18.0 | -44.2 | 23.7 | 28.9 | 25.1 | |
Effective tax rate | % | 25.3 | 29.3 | 37.4 | 20.9 | 22.6 | |
Net profit margin | % | -27.7 | -43.3 | 46.6 | 15.0 | 12.8 |
KRSNAA DIAGNOSTICS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,886 | 2,136 | 2,529 | 3,341 | 2,258 | |
Current liabilities | Rs m | 1,733 | 1,808 | 1,886 | 1,210 | 992 | |
Net working cap to sales | % | 7.3 | 12.7 | 16.2 | 46.8 | 26.0 | |
Current ratio | x | 1.1 | 1.2 | 1.3 | 2.8 | 2.3 | |
Inventory Days | Days | 56 | 56 | 41 | 102 | 140 | |
Debtors Days | Days | 98 | 87 | 69 | 46 | 55 | |
Net fixed assets | Rs m | 2,968 | 3,242 | 3,564 | 5,412 | 6,827 | |
Share capital | Rs m | 202 | 202 | 2,489 | 157 | 157 | |
"Free" reserves | Rs m | -1,051 | -2,172 | -178 | 6,667 | 7,204 | |
Net worth | Rs m | -849 | -1,970 | 2,310 | 6,824 | 7,361 | |
Long term debt | Rs m | 920 | 1,227 | 1,680 | 331 | 243 | |
Total assets | Rs m | 4,854 | 5,378 | 6,093 | 8,754 | 9,085 | |
Interest coverage | x | -3.0 | -5.4 | 12.4 | 5.7 | 11.4 | |
Debt to equity ratio | x | -1.1 | -0.6 | 0.7 | 0 | 0 | |
Sales to assets ratio | x | 0.4 | 0.5 | 0.7 | 0.5 | 0.5 | |
Return on assets | % | -7.9 | -16.2 | 34.6 | 9.9 | 7.7 | |
Return on equity | % | 68.4 | 56.8 | 80.0 | 10.0 | 8.4 | |
Return on capital | % | -818.9 | 180.0 | 80.5 | 14.7 | 11.6 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0.3 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 1 | 14 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 1 | 14 | 0 | |
Net fx | Rs m | 0 | 0 | -1 | -14 | -0 |
KRSNAA DIAGNOSTICS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 583 | 378 | 1,187 | 1,284 | 763 | |
From Investments | Rs m | -1,993 | -766 | -674 | -2,406 | -1,089 | |
From Financial Activity | Rs m | 1,243 | 58 | 200 | 1,760 | -331 | |
Net Cashflow | Rs m | -167 | -331 | 713 | 638 | -657 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Rajendra Mutha | COMP SEC: Nikhil Deshpande | YEAR OF INC: 2010 | BSE CODE: 543328 | FV (Rs): 5 | DIV YIELD (%): 0.5 |
Read: KRSNAA DIAGNOSTICS 2022-23 Annual Report Analysis
More Hospital & Healthcare Services Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare KRSNAA DIAGNOSTICS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Indian share markets Slipped further as the session progressed and ended the day weak.